首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Utility values in health technology assessments: a statistician's perspective
Authors:Caroline Whately‐Smith  Claire Watkins  Helen Mann  Chrissie Fletcher  Pierre Ducournau
Institution:1. Whately‐Smith Ltd, , King's Langley, Hertfordshire, UK;2. Global Clinical Development, Astra‐Zeneca Ltd, , Macclesfield, Cheshire, UK;3. Department of Biostatistics, Amgen Ltd, , Cambridge, Cambridgeshire, UK;4. MORSE–Global Pricing & Market Access, F. Hoffmann La Roche AG, , Basel, Switzerland
Abstract:This paper provides an introduction to utilities for statisticians working mainly in clinical research who have not had experience of health technology assessment work. Utility is the numeric valuation applied to a health state based on the preference of being in that state relative to perfect health. Utilities are often combined with survival data in health economic modelling to obtain quality‐adjusted life years. There are several methods available for deriving the preference weights and the health states to which they are applied, and combining them to estimate utilities, and the clinical statistician has valuable skills that can be applied in ensuring the robustness of the trial design, data collection and analyses to obtain and handle this data. In addition to raising awareness of the subject and providing source references, the paper outlines the concepts and approaches around utilities using examples, discusses some of the key issues, and proposes areas where statisticians can collaborate with health economic colleagues to improve the quality of this important element of health technology assessment. Copyright © 2014 John Wiley & Sons, Ltd.
Keywords:utility  quality of life  health states  QALY  EQ‐5D
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号